Effect of hormone therapy on immune response in patients with prostatic cancer.
Thirty-one patients with adenocarcinoma of the prostate had laboratory studies done for total proteins, serum immunoglobulins, white blood cell counts, lymphocyte blastogenesis, skin tests, acid phosphatase, and CEA (carcinoembryonic antigen). The 16 patients receiving no hormones had depressed total proteins, lymphocyte and monocyte counts, skin tests, and CEA compared with the 15 patients receiving hromones who had depressed serum immunoglobulins, white blood cell counts, lymphocyte blastogenesis, and acid phosphatase.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology*; D001798:Blood Proteins / Q000032:analysis; D045166:Estradiol Congeners / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000276:immunology*
D001798:Blood Proteins; D045166:Estradiol Congeners